Department of Medicine, Mayo Clinic Florida, 4500 San Pablo Road, Jacksonville, FL, 32224, USA.
Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, FL, USA.
Dig Dis Sci. 2021 Aug;66(8):2717-2723. doi: 10.1007/s10620-020-06559-x. Epub 2020 Aug 27.
Patients with Barrett's esophagus (BE) are more likely to have associated hiatal hernia (HH) compared to the general population. Studies show that HH are typically longer and wider in patients with BE.
To determine whether patients with HH have associated increased odds of coexistence of BE by examining inpatient prevalence, as well as determining other inpatient outcomes.
This was a case-control study using the NIS 2016, the largest public inpatient database in the USA. All patients with ICD10CM codes for BE were included. None were excluded. The primary outcome was determining the association between BE and HH in hospitalized patients, stratified by grade of dysplasia. Secondary outcomes included measuring use of endoscopic ablation in patients with BE and HH compared to patients with BE and no HH, determining the degree of association between HH and esophagitis in patients with or without BE, as well as the association between esophagitis and dysplasia in patients with BE and HH.
A total of 118,750 patients with BE were identified, of which 24,030 had associated HH. Adjusted odds of having associated BE in patients with HH was 10.9 (p < 0.01) compared to patients without HH. Patients with HH also displayed significantly higher odds of both low-grade dysplasia (aOR 34.5, p < 0.01) and high-grade dysplasia (aOR 14.7, p < 0.01). For secondary outcomes, the odds of undergoing ablation for BE was higher 4.77 (p < 0.01) in patients with HH.
Patients with HH have significantly higher odds of having associated BE, regardless of the level of dysplasia. Furthermore, the odds of undergoing ablation are much higher, likely reflecting higher odds of dysplasia. This highlights the importance of BE in patients with HH, and potentially consider these patients as higher risk.
与普通人群相比,巴雷特食管(BE)患者更有可能合并食管裂孔疝(HH)。研究表明,BE 患者的 HH 通常更长、更宽。
通过检查住院患者的患病率,以及确定其他住院患者的结果,来确定 HH 患者是否存在 BE 的共存风险增加。
这是一项使用 NIS 2016 的病例对照研究,NIS 2016 是美国最大的公共住院患者数据库。所有符合 BE ICD10CM 编码的患者均被纳入研究。无排除标准。主要结局是确定住院患者中 BE 与 HH 之间的关联,根据异型增生程度进行分层。次要结局包括测量 BE 和 HH 患者与 BE 无 HH 患者相比,内镜消融的使用情况,确定 BE 和无 BE 患者中 HH 与食管炎之间的关联程度,以及 BE 和 HH 患者中食管炎与异型增生之间的关联。
共确定了 118750 例 BE 患者,其中 24030 例患者合并 HH。与无 HH 的患者相比,HH 患者发生 BE 的调整比值比为 10.9(p<0.01)。HH 患者也显示出更高的低度异型增生(aOR 34.5,p<0.01)和高度异型增生(aOR 14.7,p<0.01)的可能性更高。对于次要结局,HH 患者行 BE 消融术的可能性高 4.77 倍(p<0.01)。
HH 患者发生 BE 的可能性显著增加,与异型增生的程度无关。此外,接受消融术的可能性要高得多,这可能反映出异型增生的可能性更高。这突出了 HH 患者中 BE 的重要性,并可能将这些患者视为高风险人群。